Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: Results from the caspofungin invasive aspergillosis study

被引：50

作者：

Maertens, J

Glasmacher, A

Selleslag, D

Ngai, A

Ryan, D

Layton, M

Taylor, A

Sable, C

Kartsonis, N

机构：

[1] Merck & Co Inc, Merck Res Labs, West Point, PA 19486 USA

[2] Univ Bonn, D-5300 Bonn, Germany

[3] Acad Hosp St Jan, Brugge, Belgium

[4] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

来源：

CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 01期

关键词：

D O I：

10.1086/430826

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

There has been minimal clinical experience with the use of the Aspergillus galactomannan enzyme-linked immunosorbent assay (ELISA) for patients receiving echinocandin therapy. We reviewed the experience with the galactomannan ELISA for 17 patients in a study of caspofungin treatment for invasive aspergillosis. The rate of successful outcomes for these patients was similar to that overall for participants in the study. Trends in antigenemia levels correlated with clinical and radiographic findings.

引用

页码：E9 / E14

页数：6

共 23 条

[1] ADAM O, 2002, CLIN INFECT DIS, V34, P7
[2] Aspergillosis: The most common community-acquired pneumonia with gram-negative bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease
Alangaden, GJ
Wahiduzzaman, M
Chandrasekar, PH
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (06) : 659 - 664
[3] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
Ascioglu, S
Rex, JH
de Pauw, B
Bennett, JE
Bille, J
Crokaert, F
Denning, DW
Donnelly, JP
Edwards, JE
Erjavec, Z
Fiere, D
Lortholary, O
Maertens, J
Meis, JF
Patterson, TF
Ritter, J
Selleslag, D
Shah, PM
Stevens, DA
Walsh, TJ
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 7 - 14
[4] NIAID MYCOSES STUDY-GROUP MULTICENTER TRIAL OF ORAL ITRACONAZOLE THERAPY FOR INVASIVE ASPERGILLOSIS
DENNING, DW
LEE, JY
HOSTETLER, JS
PAPPAS, P
KAUFFMAN, CA
DEWSNUP, DH
GALGIANI, JN
GRAYBILL, JR
SUGAR, AM
CATANZARO, A
GALLIS, H
PERFECT, JR
DOCKERY, B
DISMUKES, WE
STEVENS, DA
[J]. AMERICAN JOURNAL OF MEDICINE, 1994, 97 (02) : 135 - 144
[5] Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
Groll, AH
Shah, PM
Mentzel, C
Schneider, M
JustNuebling, G
Huebner, K
[J]. JOURNAL OF INFECTION, 1996, 33 (01) : 23 - 32
[6] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
Herbrecht, R
Denning, DW
Patterson, TF
Bennett, JE
Greene, RE
Oestmann, JW
Kern, WV
Marr, KA
Ribaud, P
Lortholary, O
Sylvester, R
Rubin, RH
Wingard, JR
Stark, P
Durand, C
Caillot, D
Thiel, E
Chandrasekar, PH
Hodges, MR
Schlamm, HT
Troke, PF
de Pauw, B
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) : 408 - 415
[7] Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked Immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders
Kawazu, M
Kanda, Y
Nannya, Y
Aoki, K
Kurokawa, M
Chiba, S
Motokura, T
Hirai, H
Ogawa, S
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) : 2733 - 2741
[8] Aspergillosis case - Fatality rate: Systematic review of the literature
Lin, SJ
Schranz, J
Teutsch, SM
[J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 358 - 366
[9] Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients
Maertens, J
Van Eldere, J
Verhaegen, J
Verbeken, E
Verschakelen, J
Boogaerts, M
[J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (09) : 1297 - 1306
[10] Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
Maertens, J
Verhaegen, J
Lagrou, K
Van Eldere, J
Boogaerts, M
[J]. BLOOD, 2001, 97 (06) : 1604 - 1610

← 1 2 3 →